We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Unveiling a novel fusion gene enhances CAR T cell therapy for solid tumors

    The efficacy of Adoptive Cell Transfer Therapy (ACT) in combating hematological tumors has been well-documented, yet its application to solid tumors...

    Zefeng Zhou, Yongming **a, ... Shiwei Duan in Molecular Cancer
    Article Open access 10 May 2024
  2. A novel approach for direct detection of the IGH::CRLF2 gene fusion by fluorescent in situ hybridization

    Background

    High expression of the Cytokine Receptor-Like Factor 2 ( CRLF2 ) gene has been observed in patients with acute lymphoblastic leukemia...

    Rosa María González-Arreola, Adriana García-Romero, ... Juan Ramón González-García in Molecular Cytogenetics
    Article Open access 13 August 2023
  3. One novel ACOT7–NPHP4 fusion gene identified in one patient with acute lymphoblastic leukemia: a case report

    Background

    Acute lymphoblastic leukemia (ALL) is a type of heterogeneous hematopoietic malignancy that accounts for approximately 20% of adult ALL....

    **n Zong, Zhijie Kang, ... **song Yan in BMC Medical Genomics
    Article Open access 31 October 2022
  4. Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway

    Background

    Rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene result in 8p11 myeloproliferative syndrome (EMS), which is a...

    Xuehong Zhang, Furong Wang, ... **song Yan in Cancer Cell International
    Article Open access 26 January 2022
  5. Therapeutic Fusion Proteins

    Therapeutic fusion proteins are a class of hybrid constructs that combine distinct biomolecules into a single platform with the additive effects of...

    Morgan C. Marsh, Shawn C. Owen in The AAPS Journal
    Article 30 November 2023
  6. Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma

    Chimeric fusion transcription factors are oncogenic hallmarks of several devastating cancer entities including pediatric sarcomas, such as Ewing...

    Tilman L. B. Hölting, Florencia Cidre-Aranaz, ... Maximilian M. L. Knott in Molecular Cancer
    Article Open access 13 October 2022
  7. The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer

    Background

    In breast cancer (BC), recurrent fusion genes of estrogen receptor alpha ( ESR1 ) and AKAP12 , ARMT1 and CCDC170 have been reported. In these...

    Silvia R. Vitale, Kirsten Ruigrok-Ritstier, ... Maurice P. H. M. Jansen in BMC Cancer
    Article Open access 12 February 2022
  8. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion

    Methylation class “CNS tumor with BCOR/BCOR(L1)-fusion” was recently defined based on methylation profiling and tSNE analysis of a series of 21...

    Azadeh Ebrahimi, Andreas Waha, ... Torsten Pietsch in Acta Neuropathologica Communications
    Article Open access 18 April 2024
  9. A novel BRAF::PTPRN2 fusion in meningioma: a case report

    Gene fusion events have been linked to oncogenesis in many cancers. However, gene fusions in meningioma are understudied compared to somatic...

    Nishanth S. Sadagopan, Khizar R. Nandoliya, ... Stephen T. Magill in Acta Neuropathologica Communications
    Article Open access 08 December 2023
  10. Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer

    Background

    TMPRSS2-ERG gene rearrangement, the most common E26 transformation specific (ETS) gene fusion within prostate cancer, is known to...

    Vipulkumar Dadhania, Daniel Gonzalez, ... Rohit Mehra in BMC Cancer
    Article Open access 05 May 2022
  11. Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing

    Background

    BCR::ABL1 fusion has significant prognostic value and is screened for chronic myeloid leukemia (CML) disease monitoring as a part of...

    Hyeonah Lee, Jieun Seo, ... Jong Rak Choi in Cancer Cell International
    Article Open access 29 May 2023
  12. Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance

    MSCs (mesenchymal stem cells), responsible for tissue repair, rarely undergo cell fusion with somatic cells. Here, we show that ~5% of bladder cancer...

    Youichi Tajima, Futoshi Shibasaki, Hisao Masai in Cancer Gene Therapy
    Article 21 November 2023
  13. Nanodelivery in Gene Therapy

    Gene therapy stands as a revolutionary approach in medicine, aiming to rectify genetic abnormalities by introducing therapeutic genes or regulating...
    Orhan Burak Eksi, Aybuke Ulku Kutlu, ... Omer Aydin in Handbook of Cancer and Immunology
    Living reference work entry 2024
  14. Protoplast Fusion for Cellular Engineering of the Brassicaceae

    Abstract

    The members of the Brassicaceae family are important oilseed, vegetable and forage crops. The Brassicaceae species are also used for...

    O. O. Ovcharenko, V. A. Rudas, M. V. Kuchuk in Cytology and Genetics
    Article 25 September 2023
  15. Ewing sarcoma treatment: a gene therapy approach

    Ewing sarcoma (ES) is an aggressive malignant tumor, characterized by non-random chromosomal translocations that produce fusion genes. Fusion genes...

    Sergey Tsibulnikov, Daria Fayzullina, ... Ilya Ulasov in Cancer Gene Therapy
    Article 10 April 2023
  16. MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer

    Background

    The long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 ( MALAT1 ) is a cancer biomarker. Furthermore, fusion of the MALAT1...

    Taiji Hamada, Michiyo Higashi, ... Akihide Tanimoto in BMC Cancer
    Article Open access 10 May 2023
  17. Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia

    TYK2- rearrangements have recently been identified in high-risk acute lymphoblastic leukemia (HR-ALL) cases and are associated with poor outcome....

    Paniz Tavakoli Shirazi, Laura N. Eadie, ... Deborah L. White in Cancer Gene Therapy
    Article 12 January 2022
  18. Nicotinamide Mononucleotide and Nicotinamide Riboside Reverse Ovarian Aging in Rats Via Rebalancing Mitochondrial Fission and Fusion Mechanisms

    Purpose

    This study examined the effects of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) on folliculogenesis and mitochondrial...

    Nazli Pinar Arslan, Mesut Taskin, Osman Nuri Keles in Pharmaceutical Research
    Article Open access 29 April 2024
  19. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion

    Integration of molecular data with histologic, radiologic, and clinical features is imperative for accurate diagnosis of pediatric central nervous...

    Nicholas Chapman, Joshua Greenwald, ... Jianling Ji in Acta Neuropathologica Communications
    Article Open access 22 April 2024
  20. The impact and outcomes of cancer-macrophage fusion

    Background

    Cancer’s hallmark feature is its ability to evolve, leading to metastasis and recurrence. Although genetic mutations and epigenetic changes...

    Mengtao Li, John R. Basile, ... Yi-Ling Lin in BMC Cancer
    Article Open access 01 June 2023
Did you find what you were looking for? Share feedback.